Likewise, studies of PON2-deficient murine and human B-ALL cells revealed that the loss of PON2 resulted in compromised leukemogenesis through defective glucose uptake and ATP production10. The gene discussed is PON2; the disease is precursor B-cell acute lymphoblastic leukemia.